DIAGNOSIS AND/OR RISK STRATIFICATION OF INFECTIONS AND CHRONIC DISEASES OF RESPIRATORY TRACT AND LUNGS BY MEANS OF PROVASOPRESSIN, PARTICULARLY COPEPTIN OR NEUROPHYSIN II

摘要

PROBLEM TO BE SOLVED: To provide a method for diagnosing and/or stratifying the risk of infections or chronic diseases of the respiratory tract and lungs (particularly lower respiratory tract infections and chronic obstructive pulmonary diseases).SOLUTION: Provasopressin (proAVP), or fragments or partial peptides thereof, especially copeptin or neurophysin II, is/are determined. The invention further relates to suitable biomarker combinations for in-vitro diagnosis. Provasopressins (proAVPs), or fragments and partial peptides thereof, preferably copeptin or neurophysin II, demonstrate great sensitivity and specificity for the diagnosis of infections or chronic diseases of the respiratory tracts and lungs.